The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Open accessAbstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Several lines of evidence strongly implicate mitochondrial dysfunction as a major causative factor in PD, although the molecular mechanisms responsible for mitochondrial dysfunction are poorly understood. Recently, loss-of-function mutations in the parkin gene, which encodes a ubiquitin-protein ligase, were found to underlie a familial form of PD known as autosomal recessive juvenile parkinsonism (AR-JP). To gain insight into the molecular mechanism responsible for selective cell death in AR-JP, we have created a Drosophila model of this disorder. Drosophila parkin null mutants exhibit reduced lifespan, locomotor defects, and male sterility. The locomotor defects derive from apoptotic cell death of muscle subsets, whereas the male sterile phenotype derives from a spermatid individualization defect at a late stage of spermatogenesis. Mitochondrial pathology is the earliest manifestation of muscle degeneration and a prominent characteristic of individualizing spermatids in parkin mutants. These results indicate that the tissue-specific phenotypes observed in Drosophila parkin mutants result from mitochondrial dysfunction and raise the possibility that similar mitochondrial impairment triggers the selective cell loss observed in AR-JP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, reduction of mitophagy caused by the ablation of PINK and Parkin induces mitochondrial dysfunction and increased sensitivity to oxidative stress followed by muscle degeneration [225–228].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [225]
In the citing paper
“Both excessive autophagy [140, 186] and the deficient degradation of cytosolic components [225, 226] contribute to muscle atrophy.”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [225]
In the citing paper
“whereas Parkin loss-of-function in Drosophila resulted in a decreased lifespan and increased locomotor defects [157,158].”
From Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging (2021) · cites this paper as [157]
In the citing paper
“Although there are conflicting data regarding the specific effects of these proteins on mitochondrial morphology in mammalian cells, extensive studies in Drosophila revealed that knocking out either gene caused muscle degeneration that was associated with enlarged mitochondria (Clark et al., 2006; Greene et al., 2003).”
From New insights into the role of mitochondria in aging: mitochondrial dynamics and more (2010) · cites this paper as Greene et al., 2003
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,510
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Self-citationFamilial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
Springer, W., Hoppe, T., Schmidt, E., & Baumeister, R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi371 · Cited by 113
Trinh, K., Andrews, L. A., Krause, J., Hanak, T. J., Lee, D., Gelb, M. H., & Pallanck, L. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4777-09.2010 · Cited by 112
Self-citationDisease model organism for Parkinson disease: Drosophila melanogaster
Aryal, B., & Lee, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.4.204 · Cited by 111
Mitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence
Morais, V. A., & Strooper, B. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100345 · Cited by 111
Aslanukov, A., Bhowmick, R., Guruju, M. R., Oswald, J., Raz, D., Bush, R. A., Sieving, P. A., Lu, X., Bock, C. B., & Ferreira, P. A. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020177 · Cited by 111
The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants
Vilain, S., Esposito, G., Haddad, D., Schaap, O., Dobreva, M. P., Vos, M. H., Meensel, S. V., Morais, V. A., Strooper, B. D., & Verstreken, P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002456 · Cited by 115
USP14 inhibition corrects an in vivo model of impaired mitophagy
Chakraborty, J., von Stockum, S., Marchesan, E., Caicci, F., Ferrari, V., Raković, A., Klein, C., Antonini, A., Bubacco, L., & Ziviani, E. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809014 · Cited by 114
TRAP1 rescues PINK1 loss-of-function phenotypes
Zhang, L., Karsten, P., Hamm, S., Pogson, J. H., Müller-Rischart, A. K., Exner, N., Haass, C., Whitworth, A. J., Winklhofer, K. F., Schulz, J. B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt132 · Cited by 111
Self-citationLin, C.-C., Kurashige, M., Liu, Y., Terabayashi, T., Ishimoto, Y., Wang, T., Choudhary, V., Hobbs, R. P., Liu, L., Lee, P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20856-6 · Cited by 109
Parkin is required for exercise-induced mitophagy in muscle: Impact of aging
Chen, C. C. W., Erlich, A. T., Crilly, M. J., & Hood, D. A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2017 · Cited by 108
SDHAF4 Promotes Mitochondrial Succinate Dehydrogenase Activity and Prevents Neurodegeneration
Vranken, J. G. V., Bricker, D. K., Dephoure, N., Gygi, S. P., Cox, J. E., Thummel, C. S., & Rutter, J. P. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.012 · Cited by 108
Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 109
Nakamura, T., & Lipton, S. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0476-x · Cited by 108
Parkinsonism genes: culprits and clues
Abeliovich, A., & Beal, M. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04102.x · Cited by 110
Drosophila as a Model to Study Mitochondrial Dysfunction in Parkinson's DiseasePreprint
Guo, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009944 · Cited by 111
Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms
Evans, C. S., & Holzbaur, E. L. F. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.031 · Cited by 109
Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 108
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 106
Ramonet, D., Perier, C., Recasens, A., Dehay, B., Bové, J., Costa, V., Scorrano, L., & Vila, M. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.95 · Cited by 108
ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson’s Disease
Valadas, J. S., Esposito, G., Vandekerkhove, D., Miśkiewicz, K., Deaulmerie, L., Raitano, S., Seibler, P., Klein, C., & Verstreken, P. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.022 · Cited by 107
Nakamura, T., & Lipton, S. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3570 · Cited by 104
Unravelling mitochondrial pathways to P arkinson's disease
Celardo, I., Martins, L. M., & Gandhi, S. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12433 · Cited by 105
Cox, R. T., & Spradling, A. C. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.002378 · Cited by 107
Theurey, P., & Pizzo, P. (2018) · Genes · doi:10.3390/genes9010022 · Cited by 108
Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila
Kandul, N. P., Zhang, T., Hay, B. A., & Guo, M. (2016) · Nature Communications · doi:10.1038/ncomms13100 · Cited by 109
Drosophila Models of Parkinson's Disease
Whitworth, A. J. (2011) · Advances in genetics · doi:10.1016/b978-0-12-380860-8.00001-x · Cited by 109
Self-citationThe Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia
Romanello, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010091 · Cited by 101
Mitochondrial dysfunction and Parkinson disease: a Parkin–AMPK alliance in neuroprotection
Hang, L., Thundyil, J., & Lim, K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12820 · Cited by 103
Neural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progression
Grand, J. N. L., González-Cano, L., Pavlou, M. A. S., & Schwamborn, J. C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1774-1 · Cited by 105
Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks
Csermely, P., & VÃgh, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-39975-1 · Cited by 100
Muñoz, V. F. L., & Paricio, N. (2011) · Parkinson s Disease · doi:10.4061/2011/520640 · Cited by 104
Zhou, H., Falkenburger, B. H., Schulz, J. B., Tieu, K., Xu, Z., & Xia, X. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.242 · Cited by 100
The mitochondrial kinase PINK 1: functions beyond mitophagy
Voigt, A., Berlemann, L. A., & Winklhofer, K. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13655 · Cited by 100
Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson’s Disease
Vizziello, M., Borellini, L., Franco, G., & Ardolino, G. (2021) · Cells · doi:10.3390/cells10113022 · Cited by 104
Hatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 100
Drosophila melanogaster Models of Metal-Related Human Diseases and Metal Toxicity
Calap-Quintana, P., González-Fernández, J., Sebastiá-Ortega, N., Llorens, J. V., & Moltó, M. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071456 · Cited by 100
Marmoset monkey models of Parkinson's disease: Which model, when and why?
Eslamboli, A. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.08.005 · Cited by 96
Probing Mechanisms That Underlie Human Neurodegenerative Diseases in Drosophila
Jaiswal, M., Sandoval, H., Zhang, K., Bayat, V., & Bellen, H. J. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155456 · Cited by 100
Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease
Lehmann, S., Loh, S. H. Y., & Martins, L. M. (2016) · Biology Open · doi:10.1242/bio.022186 · Cited by 96
Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism
Zheng, X., & Hunter, T. R. (2013) · Cell Research · doi:10.1038/cr.2013.66 · Cited by 97
Mechanisms of Parkinson's Disease
Hewitt, V. L., & Whitworth, A. J. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.005 · Cited by 97
Self-citationZhang, S., Feany, M. Β., Saraswati, S., Littleton, J. T., & Perrimon, N. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000653 · Cited by 101
Self-citationIntegral UBL domain proteins: a family of proteasome interacting proteins
Hartmann‐Petersen, R., & Gordon, C. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.006 · Cited by 94
Giaime, E., Yamaguchi, H., Gautier, C., Kitada, T., & Shen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040501 · Cited by 94
Of Flies and Man:Drosophilaas a Model for Human Complex Traits
Mackay, T. F. C., & Anholt, R. R. H. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115758 · Cited by 96
Parkin-dependent mitophagy in the heart
Dorn, G. W. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.023 · Cited by 95
Imai, Y., Kanao, T., Sawada, T., Kobayashi, Y., Moriwaki, Y., Ishida, Y., Takeda, K., Ichijo, H., Lu, B., & Takahashi, R. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001229 · Cited by 95
Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo
Gorsky, M. K., Burnouf, S., Dols, J., Mandelkow�, E., & Partridge, L. (2016) · Scientific Reports · doi:10.1038/srep22685 · Cited by 94
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
Taylor, J. P., Mata, I. F., & Farrer, M. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.004 · Cited by 94
Genes associated with Parkinson's disease: regulation of autophagy and beyond
Beilina, A. G., & Cookson, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13266 · Cited by 98
Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
Trancikova, A. K., Tsika, E., & Moore, D. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4200 · Cited by 94
Modelling Parkinson’s Disease in Drosophila
Botella, J., Bayersdorfer, F., Gmeiner, F., & Schneuwly, S. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8098-6 · Cited by 95
Mitochondrial Protein Quality Control Mechanisms
Jadiya, P., & Tomar, D. (2020) · Genes · doi:10.3390/genes11050563 · Cited by 93
Lavara-Culebras, E., & Paricio, N. (2007) · Gene · doi:10.1016/j.gene.2007.06.013 · Cited by 92
Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin
Tain, L. S., Chowdhury, R. B., Tao, R., Plun‐Favreau, H., Moisoi, N., Martins, L. M., Downward, J., Whitworth, A. J., & Tapon, N. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.23 · Cited by 93
Self-citationPellegrino, M. W., & Haynes, C. M. (2015) · BMC Biology · doi:10.1186/s12915-015-0129-1 · Cited by 99
Toxin-Induced and Genetic Animal Models of Parkinson's Disease
Hisahara, S., & Shimohama, S. (2010) · Parkinson s Disease · doi:10.4061/2011/951709 · Cited by 95
Cheng, M., Liu, L., Lao, Y., Liao, W., Liao, M., Luo, X., Wu, J., Xie, W., Zhang, Y., & Xu, N. (2016) · Oncotarget · doi:10.18632/oncotarget.9786 · Cited by 92
Ubiquitin-Proteasome System–Regulated Protein Degradation in Spermatogenesis
Xiong, Y., Yu, C. Y., & Zhang, Q. (2022) · Cells · doi:10.3390/cells11061058 · Cited by 94
Genetics of parkin-linked disease
West, A. B., & Maidment, N. T. (2004) · Human Genetics · doi:10.1007/s00439-003-1074-6 · Cited by 90
Shulman, J. M., Shulman, L. M., Weiner, W. J., & Feany, M. Β. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084220.82329.60 · Cited by 90
Self-citationAutophagy inDrosophila: From Historical Studies to Current Knowledge
Mulakkal, N. C., Nagy, P., Takáts, S., Tusco, R., Juhász, G., & Nezis, I. P. (2014) · BioMed Research International · doi:10.1155/2014/273473 · Cited by 93
PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy
Wu, Y., Jiang, T., Hua, J., Xiong, Z., Dai, K., Chen, H., Li, L., Peng, J., Peng, X., Zheng, Z., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.05.025 · Cited by 91
Mechanisms, pathophysiological roles and methods for analyzing mitophagy – recent insights
Williams, J. A. R., & Ding, W. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0228 · Cited by 92
Genetics of Parkinson’s disease and related disorders
Zhang, P.-L., Chen, Y., Zhang, C.-H., Wang, Y., & Fernández-Fúnez, P. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105047 · Cited by 93
Pirooznia, S. K., Yuan, C., Khan, M. R., Karuppagounder, S. S., Wang, L., Xiong, Y., Kang, S. U., Lee, Y., Dawson, V. L., & Dawson, T. M. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00363-x · Cited by 91
Malik, B. R., Godena, V. K., & Whitworth, A. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv322 · Cited by 90
Self-citationRet rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants
Klein, P., Müller-Rischart, A. K., Motori, E., Schönbauer, C., Schnorrer, F., Winklhofer, K. F., & Klein, R. (2014) · The EMBO Journal · doi:10.1002/embj.201284290 · Cited by 90
Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
Peris-Moreno, D., Cussonneau, L., Combaret, L., Polge, C., & Taillandier, D. (2021) · Molecules · doi:10.3390/molecules26020407 · Cited by 90
Davison, E. J., Pennington, K., Hung, C., Peng, J., Rafiq, R., Ostareck‐Lederer, A., Ostareck, D. H., Ardley, H. C., Banks, R. E., & Robinson, P. A. (2009) · PROTEOMICS · doi:10.1002/pmic.200900126 · Cited by 88
Norris, K. L., Hao, R., Chen, L., Lai, C.-H., Kapur, M., Shaughnessy, P. J., Chou, D., Yan, J., Taylor, J. P., Engelender, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.634063 · Cited by 88
The Fly as a Model for Neurodegenerative Diseases: Is It Worth the Jump?
Cauchi, R. J., & van den Heuvel, M. (2006) · Neurodegenerative Diseases · doi:10.1159/000097303 · Cited by 91
Kumaran, R., & Cookson, M. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv236 · Cited by 86
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 91
Yun, J., Cao, J. H., Dodson, M. W., Clark, I. E., Kapahi, P., Chowdhury, R. B., & Guo, M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5141-08.2008 · Cited by 87
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease
Büeler, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0465-0 · Cited by 87
Myopathy causing camptocormia in idiopathic Parkinson's disease: A multidisciplinary approach
Spuler, S., Krug, H., Klein, C., Medialdea, I. C., Jakob, W., Ebersbach, G., Gruber, D., Hoffmann, K., Trottenberg, T., & Kupsch, A. R. (2009) · Movement Disorders · doi:10.1002/mds.22913 · Cited by 85
Pogson, J. H., Ivatt, R. M., Sánchez-Martínez, Á., Tufi, R., Wilson, E. L., Mortiboys, H., & Whitworth, A. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004815 · Cited by 87
Self-citationAutophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Arotçarena, M.-L., Teil, M., & Dehay, B. (2019) · Cells · doi:10.3390/cells8060565 · Cited by 91
Mitochondrial quality control: The role of mitophagy in aging
Shi, R., Guberman, M., & Kirshenbaum, L. A. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.11.008 · Cited by 87
Varland, S., Silva, R. D., Kjosås, I., Faustino, A., Bogaert, A., Billmann, M., Boukhatmi, H., Kellen, B., Costanzo, M., Drazic, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42342-y · Cited by 85
Self-citationParkin Protects against Mitochondrial Toxins and β-Amyloid Accumulation in Skeletal Muscle Cells
Rosen, K. M., Veereshwarayya, V., Moussa, C., Fu, Q., Goldberg, M. S., Schlossmacher, M. G., Shen, J., & Querfurth, H. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512649200 · Cited by 84
Progress in the pathogenesis and genetics of Parkinson's disease
Mizuno, Y., Hattori, N., Kubo, S., Sato, S., Nishioka, K., Hatano, T., Tomiyama, H., Funayama, M., Machida, Y., & Mochizuki, H. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.2273 · Cited by 86
Julienne, H., Buhl, E., Leslie, D. S., & Hodge, J. J. L. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.014 · Cited by 90
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 87
Mitochondrial dismissal in mammals, from protein degradation to mitophagy
Campello, S., Strappazzon, F., & Cecconi, F. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.11.010 · Cited by 88
Sung, H., Tandarich, L. C., Nguyen, K. K., & Hollenbeck, P. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0633-16.2016 · Cited by 85
A Critical Review of Zebrafish Models of Parkinson’s Disease
Doyle, J. M., & Croll, R. P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.835827 · Cited by 94
Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release
Berger, A. K., Cortese, G. P., Amodeo, K. D., Weihofen, A., Letai, A. G., & LaVoie, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp384 · Cited by 84
Quantitative proteomic analysis of Parkin substrates in Drosophila neurons
Martinez, A., Lectez, B. L. P., Ramírez, J., Popp, O., Sutherland, J. D., Urbé, S., Dittmar, G., Clague, M. J., & Mayor, U. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0170-3 · Cited by 86
Brain Mitochondria, Aging, and Parkinson’s Disease
Rango, M., & Bresolin, N. (2018) · Genes · doi:10.3390/genes9050250 · Cited by 87
Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
Gao, F., Yang, J. Y., Wang, D., Li, C., Fu, Y., Wang, H., He, W., & Zhang, J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00527 · Cited by 84
Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
Kamienieva, I., Duszyński, J., & Szczepanowska, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-020-00229-8 · Cited by 84
Parkin Regulation and Neurodegenerative Disorders
Zhang, C., Hang, L., Yao, T., & Lim, K. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00248 · Cited by 84
Muqit, M. M. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh012 · Cited by 82
Bian, M., Liu, J., Hong, X., Yu, M., Huang, Y., Sheng, Z., Fei, J., & Huang, F. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039953 · Cited by 85
Weil, R., Laplantine, E., Curic, S., & Génin, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01243 · Cited by 83
Ambegaokar, S. S., Roy, B., & Jackson, G. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.026 · Cited by 80
Parkin Suppresses the Expression of Monoamine Oxidases
Jiang, H., Jiang, Q., Liu, W., & Feng, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510926200 · Cited by 80
Mitochondrial Dynamics and Parkinson's Disease: Focus on Parkin
Lim, K.-L., Ng, X.-H., Grace, L. G.-Y., & Yao, T.-P. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4105 · Cited by 64
Metadata
- Authors
- Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Department of Genome Sciences, University of Washington, P.O. Box 357730, Seattle, WA 98195; and Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-03-17
- Volume
- 100
- Issue
- 7
- Pages
- 4078-4083
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC153051
- OpenAlex
- W2055124287
- Cited by
- 1,203
- References
- 34
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 34 · 2023: 38 · 2022: 49 · 2021: 64 · 2020: 68 · 2019: 50 · 2018: 64 · 2017: 54 · 2016: 69 · 2015: 56 · 2014: 55 · 2013: 64 · 2012: 67
- FWCI
- 27.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS041780, 1R01NS41780-01, 1R01NS41536-01, R01NS041536)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkin, Parkinson's disease, autosomal recessive juvenile parkinsonism, mitochondrial dysfunction, muscle degeneration, apoptosis, Drosophila model, ubiquitin-protein ligase, spermatid individualization, male sterility, locomotion defects, lifespan, selective cell death
- MeSH terms
- Amino Acid Sequence, Animals, Cloning, Molecular, Drosophila, Ligases, Longevity, Male, Mitochondria, Molecular Sequence Data, Nerve Degeneration, Parkinson Disease, Recombinant Proteins, Spermatids, Mutagenesis, Sequence Alignment, Apoptosis, Sequence Homology, Amino Acid, Muscle, Skeletal, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
